These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11397680)

  • 1. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E; Meunier PJ
    Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
    de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M
    Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical assessment of Paget's disease of bone.
    Shankar S; Hosking DJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and management of Paget's disease of bone].
    Hashimoto J; Yoshikawa H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():56-64. PubMed ID: 18161082
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
    Sharp CA; Worsfold M; Rowlands PR; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Vidal S; Ros I; Monegal A; Bedini JL; Deulofeu R; Pons F; Muñoz-Gomez J; Ballesta AM
    Bone; 2001 Nov; 29(5):447-52. PubMed ID: 11704497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical markers for bone metabolism--overview].
    Nakatsuka K; Nishizawa Y
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():220-7. PubMed ID: 11979911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
    de la Piedra Gordo C; Torres Jiménez R
    An Med Interna; 1990 Oct; 7(10):534-8. PubMed ID: 2104101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical measurements in Paget's disease of bone.
    Russell RG; Colwell A; Hannon RA; Blumsohn A; al-Dehaimi AW; Assiri AM; Peel NF; Eastell R
    Semin Arthritis Rheum; 1994 Feb; 23(4):240-1. PubMed ID: 8009238
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnosis of Paget's disease.
    Pande I
    Practitioner; 2001 Sep; 245(1626):730-5. PubMed ID: 11584586
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R; Eisinger J; Recordier AM
    Rhumatologie; 1971 Apr; 23(4):119-39. PubMed ID: 4254981
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis.
    Honjo S; Mizunuma H
    Am J Obstet Gynecol; 2001 Jul; 185(1):246-7. PubMed ID: 11483939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paget's disease of the bones: diagnosis and treatment].
    Jacobs JW; Huisman AM; van Paassen HC; Bijlsma JW
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):719-25. PubMed ID: 10347626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.